Anti-dengue activity: In vitro DENV-2 NS2B/NS3 protease inhibitory activity1–2: less than 70% inhibition at 200 μg/mL.3: IC50 = 27.33 ± 5.45 μM5: IC50 = 7.55 ± 1.64 μMQuercetin (positive control): IC50 = 10.48 ± 2.14 μM. The gene discussed is KRAS; the disease is dengue disease.